Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$2.89 - $5.32 $183,607 - $337,990
-63,532 Reduced 61.44%
39,879 $118,000
Q1 2022

May 16, 2022

BUY
$7.56 - $14.3 $205,745 - $389,174
27,215 Added 35.72%
103,411 $847,000
Q4 2021

Feb 14, 2022

BUY
$12.24 - $21.25 $130,258 - $226,142
10,642 Added 16.23%
76,196 $1.09 Million
Q3 2021

Nov 15, 2021

BUY
$16.69 - $26.05 $362,790 - $566,248
21,737 Added 49.61%
65,554 $1.26 Million
Q2 2021

Aug 11, 2021

BUY
$18.15 - $27.75 $795,278 - $1.22 Million
43,817 New
43,817 $1.11 Million

Others Institutions Holding PSNL

About Personalis, Inc.


  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $171M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track This Portfolio

Track Susquehanna Fundamental Investments, LLC Portfolio

Follow Susquehanna Fundamental Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.